• Recent news

  • Woulgan publication in Sårmagasinet nr. 3 2018

    The woundclinic at Mälersjukehuset in Sweden has tested Woulgan as part of a bigger case study evaluation. Of the 11 wounds evaluated,  9 were completly healed or showed more than a 50% size reduction. The completely healed wounds healed within a 4 week treatment period. The results from this study were compiled and published in Sårmagasinet number 3 2018, authored by…

    Continue reading

Latest presentation

First quarter 2018 results

Loading video...

Biotec Pharmacon ASA (”Biotec”, OSE: BIOTEC) reported sales of NOK 14.2 million (18.2) in the first quarter of 2018, and a negative EBITDA of NOK 5.9 million (-4.1). Woulgan® generated sales of NOK 0.5 million during the first quarter whereas ArcticZymes generated sales of NOK 6.3 milllion. During the first quarter, results…

View more